GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fujian Cosunter Pharmaceutical Co Ltd (SZSE:300436) » Definitions » Net Change in Cash

Fujian Cosunter Pharmaceutical Co (SZSE:300436) Net Change in Cash : ¥-84.7 Mil (TTM As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Fujian Cosunter Pharmaceutical Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Fujian Cosunter Pharmaceutical Co's Net Change in Cash for the three months ended in Mar. 2025 was ¥-24.4 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-84.7 Mil.

Fujian Cosunter Pharmaceutical Co Net Change in Cash Historical Data

The historical data trend for Fujian Cosunter Pharmaceutical Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fujian Cosunter Pharmaceutical Co Net Change in Cash Chart

Fujian Cosunter Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.27 253.43 -154.36 -32.29 -59.56

Fujian Cosunter Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.69 -72.67 -3.74 16.16 -24.45

Fujian Cosunter Pharmaceutical Co Net Change in Cash Calculation

Fujian Cosunter Pharmaceutical Co's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=20.708+-45.812+-34.457+0
=-59.6

Fujian Cosunter Pharmaceutical Co's Net Change in Cash for the quarter that ended in Mar. 2025

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-12.553+-11.484+-0.41+0
=-24.4

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-84.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fujian Cosunter Pharmaceutical Co Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Fujian Cosunter Pharmaceutical Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Fujian Cosunter Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fujian Cosunter Pharmaceutical Co Ltd (SZSE:300436) » Definitions » Net Change in Cash
Comparable Companies
SHSE:688566 SZSE:300194 SZSE:002688 SZSE:002793 SHSE:603676 SHSE:688176 SZSE:301277 SZSE:301393 SZSE:301211 SHSE:688247 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
Software Park, No. 89, Software Avenue, Block B, Building 10, Zone B, Gulou District, Fujian, Fuzhou, CHN, 350003
Website
http://www.cosunter.com
Fujian Cosunter Pharmaceutical Co Ltd is a pharmaceutical company engaged in the pharmaceutical production, sales and Research and Development. Its specialized in the field of hepatitis B medicine. Its product includes Fuganding-tenofovir disoproxil fumarate capsule, Enganding-Entecavir Capsules, He Ganding-Lamifuzed tablets and Agandan-adefovir dipivoxil tablets.
Executives
Li Guo Ping Directors, executives
Huang Fu Hu Directors, executives
Li Hong Ming Directors, executives
Guan Jian Hui Executives
Lin Xiao Hui Directors, Directors, and Executives
Ye Li Qing Director
Li Yuan Li Supervisors
Zheng Li Feng Supervisors
Li Guo Dong Directors, executives

Fujian Cosunter Pharmaceutical Co Headlines

No Headlines